In 2016, representatives from the British Society for Haematology (BSH) and haematologists from low- and middle-income countries (LMIC) met to decide the priorities of the Global Haematology Special Interest Group (SIG).
One priority was identifying BSH speakers to visit LMIC haematology meetings to establish links and collaborative projects.
We built on the success of the 2017 pilot project to establish the Plenary Speaker Project as a core activity of the SIG. In 2023, we rebranded the scheme as BSH Global Speakers to better communicate our vision for the project.
The BSH Global Speakers Task Force is accepting applications for the BSH Global Speakers Scheme. This scheme aims to form collaborative partnerships between the BSH and haematology societies in low- and middle-income countries (LMIC), for sharing knowledge and expertise.
We are looking for speakers from medical, nursing or scientific backgrounds for:
Haem Icon 2024: The Annual Academic Sessions of the Sri Lanka College of Haematologists
26-28 September 2024
A speaker with expertise in one of the following areas is requested:
Haemato-oncology
- Updates in CLL, MCL, or HL
- Updates in MDS and AML in the elderly patient
- Updates in MPN diagnosis and management
Haemostasis and thrombosis
- Haemophilia management beyond factor replacement
- Coagulopathy in liver disease
Aplastic anaemia and PNH
HLH
Transfusion, including massive haemorrhage
The selected speaker for Haem Icon 2024 will also be invited to present at a pre-congress workshop on a topic relevant to their expertise.
We look forward to hearing from you. If you have any queries please contact [email protected].
Deadline: Friday, 10 May 2024.
Eligibility: you must be a BSH member to apply.
Apply to become a BSH Global Speaker.
The Hematology-Blood Transfusion Society of Vietnam’s National Conference of Hematology and Blood Transfusion
November 2024
A speaker with expertise in one of the following areas is requested:
Stem cell transplantation
- Cord blood transplantation
- Use of mesenchymal stem cells
- Clinical and scientific aspects of CAR-T
Haemostasis and thrombosis
- Update on the diagnosis and management of Von Willebrand disease
- Thrombosis in pregnancy
- Paediatric thrombosis
The speaker selected for the conference in Vietnam will also be invited to additional meetings with clinicians and scientists for further discussion on the subject of interest.
We hope the Global Speaker programme will encourage an ongoing exchange of expertise. We therefore encourage applicants to use this opportunity to collaborate on, for example, educational or capacity-building projects, or co-authored evidence-based guidelines.
Applications will be reviewed by a panel and applicants will be notified of the outcome within 3 weeks of the closing date. This project is always evolving, and we hope to work closely with our international partner societies and the BSH Global Speakers during both planning and evaluation stages.
We look forward to hearing from you. If you have any queries please contact [email protected].
Deadline: Friday, 10 May 2024.
Eligibility: you must be a BSH member to apply.
About the programme
Making links, creating networks
The initial phases of this programme involved mapping out and making contacts with active haematology and transfusion societies in LMICs worldwide.
We searched for active haematology societies in LMICs in Africa, Europe, the Middle East and Asia.
We contacted attendees from LMICs at the 2016 BSH international congress, and we asked respondents about active haematology societies in their region. We conducted internet searches and contacted haematologists and transfusion specialists in large teaching hospitals in LMICs.
We shortlisted LMIC haematology societies for our 2017 pilot scheme based on pre-defined criteria. We invited the Ghanaian Society of Haematology (GHASH) and the Haematology and Oncology Society of Africa (HOSA) to take part.
Previous attendees:
2017: Dr Hume Ahmad - Accra, Ghana - Challenging diagnostic cases in anaemia.
2017: Dr Maadh Aldouri - Nairobi, Kenya - Treating lymphoma in low resource settings.
2018: Dr Noemi Roy - Cairo, Egypt - Dyserythropoesis and the use of NGS in rare anaemias.
2019: Dr Anita Hill - Colombo, Sri Lanka - Update in PNH.
2019: Dr Ben Kennedy - Bangkok, Thailand - Update in CLL.
2021: Dr Jecko Thachil - South Africa - Coagulopathy and COVID-19.
2021: Dr Nandini Sadasivam - Vietnam - Update in care for patients with thalassaemia.
2022: Dr Richard Dillon - Egypt - Molecularly guided interventions to prevent relapse in AML.
2022: Dr Keith Gomez - Ghana - Anticoagulation: challenging cases.
2023: Dr Bill Grey - Thailand - Targeting protein homeostasis to eradicate acute myeloid leukaemia stem cells and protect health issues.
2023: Miss Lucy Wheeler - Egypt - MRD in acute leukaemia: a 'different from normal' approach.